Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST).

Name: Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST).
Author: Ten Doesschate, Thijs

Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST). — المؤلف: Ten Doesschate, Thijs — BMC infectious diseases 20190128

المؤلف: Ten Doesschate, Thijs
النشر: BMC infectious diseases 20190128
الوصف: 626 p.
الموضوعات: Administration, Intravenous؛ Administration, Oral؛ Adolescent؛ Adult؛ Aged؛ Aged, 80 and over؛ Anti-Bacterial Agents؛ Ciprofloxacin